Vasoptic Medical, Inc.
1-in-3 diabetics has a condition that leads to blindness. Our low-cost solution will diagnose it early and create $300m in US sales by 2020.
Vasoptic Medical is an early stage, medical device company developing a low-cost, mobile solution for early diagnosis and management of diabetic retinopathy (DR) in managed care, telehealth, and primary care settings. Unlike existing solutions, our device extracts quantitative information of both structure and function of retinal blood vessels without dyes or pupil dilation, making routine screening cost-effective and convenient for diabetics.